Iodine Supplement Strategies Between Routine Iodine Supplementation and Selective Iodine Supplementation
NCT ID: NCT03078140
Last Updated: 2018-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
208 participants
INTERVENTIONAL
2017-05-01
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Correlation Between Iodine and Selenium Status in Pregnancy and Risk of Thyroid Disease
NCT03761602
Longitudinal Study on the Influence of Iodine Nutrition Status on Thyroid Function of Childbearing Age Women During Pregnancy and 6 Weeks Postpartum
NCT05677581
Thyroid Function Throughout Pregnancy With and Without Iodine Supplementation
NCT00831402
Iodine Status Monitoring in PortUguese Pregnant woMen: Impact of Supplementation
NCT04010708
The Effect of Iodine Intakes on Maternal and Infant Health and the Study of Iodine RNI for Different Stages of Pregnancy
NCT03710148
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Triferdine
Triferdine 1 tablet by mouth daily. Start after 1st trimester until delivery
Triferdine
Triferdine 1 tablet daily Start from 14 weeks of gestation until delivery
Triferdine/Ferli-6
Triferdine or ferli-6 1 tablet by mouth daily base on iodine status. The supplement will give after 1st trimester until delivery
Triferdine/Ferli-6
For the participants assigned to this group, urine iodine level will be checked first.
For participants with normal urine iodine level, Ferli-6 1 tab daily will be given.
For those with low urine iodine level, Triferdine 1 tab daily will be given. Medication will be started from 14 weeks of gestation until delivery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Triferdine
Triferdine 1 tablet daily Start from 14 weeks of gestation until delivery
Triferdine/Ferli-6
For the participants assigned to this group, urine iodine level will be checked first.
For participants with normal urine iodine level, Ferli-6 1 tab daily will be given.
For those with low urine iodine level, Triferdine 1 tab daily will be given. Medication will be started from 14 weeks of gestation until delivery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* singleton pregnancy
* delivered at Maharaj Nakorn Chiangmai Hospital
Exclusion Criteria
* history of thyroid gland surgery or iodine ablation therapy
* received iodine supplement before pregnancy
* received any medication for thyroid disease treatment, within 6 weeks postpartum women or breast feeding period
* family history of thyroid disease
* having underlying disease or contraindication which cannot received iodine supplement
* loss follow-up or incomplete data.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chiang Mai University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kuntharee Traisrisilp
Principle Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kuntharee Traisrisilp
Chiang Mai, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4298
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.